Bioinformatics market seen reaching $150.67B by 2033

By AI, Created 4:37 PM UTC, May 18, 2026, /AGP/ – Coherent Market Insights says the bioinformatics market was valued at $39.22 billion in 2026 and is projected to reach $150.67 billion by 2033. The report points to genomics demand, segmented growth across platforms and services, and a crowded competitive field as major drivers for investors and industry players.

Why it matters: - The bioinformatics market is forecast to more than triple from $39.22 billion in 2026 to $150.67 billion by 2033. - The report frames the sector as a key opportunity for companies, investors and stakeholders tracking genomics, drug design and other data-heavy life sciences workflows. - Market sizing, segment forecasts and regional analysis can shape product strategy, investment timing and market entry decisions.

What happened: - Coherent Market Insights published “Bioinformatics Market 2026” on May 14, 2026. - The report covers market trends from 2026 through 2033 across regional and global markets. - The study includes projections for market size, production, revenue, consumption, CAGR, gross margin and pricing trends. - The report also breaks the market into bioinformatics platforms and bioinformatics services. - Application coverage includes genomics, chemoinformatics and drug design, proteomics, transcriptomics, metabolomics, molecular phylogenomics and other uses. - A sample copy is available here.

The details: - The report says it uses primary and secondary research methods. - It combines qualitative and quantitative analysis of market dynamics, pricing structures, production-consumption patterns, company profiles and cost analysis. - The competitive review includes market share analysis, competitive positioning and benchmarking, segmented revenue insights, and tracking of strategic developments and innovation. - The report profiles Active Motif, Illumina, Life Technologies, Affymetrix, Agilent Technologies, Bio-Rad Laboratories, Qiagen, Knome, GE Healthcare, Geneva Bioinformatics, Quest Diagnostics, bitBiome, Intomics, Advanced BioInformatics and Fios Genomics. - Regional coverage spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. - The geographic list includes the United States, Canada, Mexico, Germany, France, the UK, Italy, Russia, China, Japan, India, South Korea, Southeast Asia, Brazil, Argentina, Colombia, Saudi Arabia, the UAE, Egypt, Nigeria and South Africa. - The report says it also examines demographic, geographic, psychographic and behavioral factors influencing demand. - A second sample request link appears in the release: Request sample report. - The release also points readers to a discounted purchase option here.

Between the lines: - The report is positioned as a buying and strategy tool, not just a market snapshot. - The focus on competitive benchmarking and segment-level revenue suggests firms are being pushed to target specific niches rather than the market as a whole. - The emphasis on genomics and bioinformatics platforms signals where demand may be strongest as life sciences workflows become more data intensive.

What’s next: - Stakeholders are expected to use the forecast period through 2033 to test investment plans and product road maps. - The report signals continued attention to regional expansion, pricing models and new applications across bioinformatics. - Coherent Market Insights says its findings are intended to support growth planning and competitive positioning over the next several years.

The bottom line: - Bioinformatics is being sized as a high-growth market with broad regional and application-level opportunity, and the report suggests competition will increasingly hinge on specialized platforms, services and segment-specific strategies.